Brentuximab vedotin only product in parenteral dose form
|
Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug)
Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial
Id1209036004
StatusDefined
Has manufactured dose formPowder for solution for infusion and/or injection
Has unit of presentationVial
Plays roleAntineoplastic therapeutic role
Has BoSSBrentuximab vedotin
Has precise active ingredientBrentuximab vedotin
Has presentation strength denominator unitVial
Has presentation strength numerator unitmg
|
Brentuximab vedotin 50 mg powder for solution for infusion vial
Brentuximab vedotin 50 mg powder for solution for injection vial